.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Healthtrust
Federal Trade Commission
Novartis
Queensland Health
Mallinckrodt
Cipla
US Department of Justice
Boehringer Ingelheim
Cantor Fitzgerald

Generated: November 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nelarabine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp
ARRANON
nelarabine
INJECTABLE;IV (INFUSION)021877NDAGlaxoSmithKline LLC0007-4401-066 VIAL, GLASS in 1 CARTON (0007-4401-06) > 50 mL in 1 VIAL, GLASS (0007-4401-01)
Novartis Pharms Corp
ARRANON
nelarabine
INJECTABLE;IV (INFUSION)021877NDANovartis Pharmaceuticals Corporation0078-0683-066 VIAL in 1 CARTON (0078-0683-06) > 50 mL in 1 VIAL (0078-0683-61)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Johnson and Johnson
Daiichi Sankyo
Dow
Fuji
US Army
Covington
Teva
Accenture

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot